gvtcx

Evaluation of Buvidal

Llywodraeth Cymru / Welsh Government Published 8 Mar 2023 Sell2Wales

key details

Value£650,000
Statuscomplete
Category (CPV) 73000000 +7 more
RegionWales
Deadline6 Feb 2023
Procedureopen
OCIDocds-h6vhtk-038de1

Award

SupplierValueDateStatus
USW Commercial Services Ltd · · active

description

The Welsh Government (WG) wishes to commission an evaluation of the rapid implementation of Injectable Buprenorphine (Buvidal) which forms part of the range of interventions within opioid substitution treatment (OST) services. Buvidal is a new form of OST which replaces the need for daily supervised consumption with weekly or monthly injections.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
15 Dec 2022 Contract notice (F02) Earlier regulations 035551-2022
8 Mar 2023 Contract award notice (F03) Earlier regulations 006802-2023

more from Llywodraeth Cymru / Welsh Government

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Sell2Wales. Contact details for named individuals are not reproduced on this site.